Industry Briefs: Mar. 12, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Amgen has completed its tender offer for the outstanding shares of Micromet. Read More
Celgene has completed its acquisition of Avila Therapeutics. Read More
EMD Millipore and the Centre for Commercialization of Regenerative Medicine have agreed to develop optimized conditions for bioreactor-based cultivation of stem cells.
Marken plans to open four additional logistics branches in India. Read More
Mylan plans to build a new corporate headquarters near its current location in the Southpointe Office Park located in Cecil Township, Pennsylvania. Read More
SCM Pharma invests in an expansion of its vial-filling capabilities. Read More
Valeant Pharmaceuticals has agreed to acquire certain assets from Gerot Lannach. Read More
Valeant Pharmaceuticals has acquired a 19.9% minority equity investment in Pele Nova Biotecnologia. Read More
People News
Catalent Pharma Solutions has named Jeremie Trochu to the newly created position of vice-president of commercial excellence, effective immediately. Read More
Hovione has appointed Colin Minchom as vice-president of its particle-design business unit. Read More
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
